HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Aurobindo Pharma’s arm restarts Penicillin-G manufacturing facility in AP
Jun-30-2025

Aurobindo Pharma’s wholly owned stepdown subsidiary -- Lyfius Pharma has re-started the production at its Penicillin-G manufacturing facility, at Kakinada, Andhra Pradesh (AP), with immediate effect, after receiving the consent to operate (CTO) from Andhra Pradesh from Andhra Pradesh Pollution Control Board (APPCB), on June 29, 2025.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

  RELATED NEWS >>